Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers
Open Access
- 2 May 2023
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 42 (23) , 1875-1888
Abstract
Rare but recurrent mutations in the fibroblast growth factor receptor (FGFR) pathways, most commonly in one of the four FGFR receptor tyrosine kinase genes, can potentially be targeted with broad-spectrum multi-kinase or FGFR selective inhibitors. The complete spectrum of these mutations in paediatric cancers is emerging as precision medicine programs perform comprehensive sequencing of individual tumours. Identification of patients most likely to benefit from FGFR inhibition currently rests on identifying activating FGFR mutations, gene fusions, or gene amplification events. However, the expanding use of transcriptome sequencing (RNAseq) has identified that many tumours overexpress FGFRs, in the absence of any genomic aberration. The challenge now presented is to determine when this indicates true FGFR oncogenic activity. Under-appreciated mechanisms of FGFR pathway activation, including alternate FGFR transcript expression and concomitant FGFR and FGF ligand expression, may mark those tumours where FGFR overexpression is indicative of a dependence on FGFR signalling. In this review, we provide a comprehensive and mechanistic overview of FGFR pathway aberrations and their functional consequences in paediatric cancer. We explore how FGFR over expression might be associated with true receptor activation. Further, we discuss the therapeutic implications of these aberrations in the paediatric setting and outline current and emerging therapeutic strategies to treat paediatric patients with FGFR-driven cancers.Keywords
This publication has 130 references indexed in Scilit:
- Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersApoptosis, 2013
- FGFR1 cleavage and nuclear translocation regulates breast cancer cell behaviorJournal of Cell Biology, 2012
- The Alternatively Spliced Acid Box Region Plays a Key Role in FGF Receptor AutoinhibitionStructure, 2012
- Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1–PI3K–Rac1 pathwayBritish Journal of Cancer, 2010
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 ActivationJournal of Biological Chemistry, 2010
- Phosphorylation of the SSBP2 and ABL proteins by the ZNF198‐FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide‐specific MSProteomics, 2009
- The Precise Sequence of FGF Receptor Autophosphorylation Is Kinetically Driven and Is Disrupted by Oncogenic MutationsScience Signaling, 2009
- Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer CellsMolecular Pharmacology, 2009
- FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activitiesOncogene, 2008
- Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3Nature Genetics, 1996